Back
Immunovant Vs. Viking Therapeutics Industry Stock Comparison
Buy
52
IMVT
Immunovant
Last Price:
29.39
Seasonality Move:
22.4%
Buy
61
VKTX
Viking Therapeutics
Last Price:
72.89
Seasonality Move:
35.84%
Buy
52
Immunovant (IMVT)
is a Buy
Is Immunovant a Buy, Sell or Hold?
- The current Immunovant [IMVT] share price is $29.39. The Score for IMVT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- IMVT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
Viking Therapeutics (VKTX)
is a Buy
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $72.88. The Score for VKTX is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- VKTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IMVT Stock Price Chart
What is Immunovant's stock price today?
-
The Immunovant share price today is $29.39
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IMVT is experiencing slight selling pressure.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $72.88
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.
IMVT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 47.64 | Sell |
| Chaikin Money Flow: | -135610 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.91 - 30.19) | Sell |
| Bollinger Bands (100): | (27.41 - 30.87) | Buy |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.7 | Buy |
| Relative Strength Index (14 RSI): | 58.87 | Buy |
| Chaikin Money Flow: | -2173078 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (61.93 - 71.45) | Buy |
| Bollinger Bands (100): | (52.76 - 66.5) | Buy |
IMVT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.93 | Sell |
| 20-day SMA: | 29.75 | Sell |
| 50-day SMA: | 29.94 | Sell |
| 200-day SMA: | 30.63 | Sell |
| 8-day EMA: | 29.71 | Sell |
| 20-day EMA: | 29.68 | Sell |
| 50-day EMA: | 29.62 | Sell |
| 200-day EMA: | 29.73 | Sell |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 72.08 | Buy |
| 20-day SMA: | 67.57 | Buy |
| 50-day SMA: | 64.45 | Buy |
| 200-day SMA: | 59.6 | Buy |
| 8-day EMA: | 71.57 | Buy |
| 20-day EMA: | 68.66 | Buy |
| 50-day EMA: | 65.15 | Buy |
| 200-day EMA: | 55.25 | Buy |
Immunovant Earnings Growth & IMVT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.16 per share, and a decrease next year of $0.66 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.50 per share.
Immunovant Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||